Publications by authors named "R R Karn"

Highly porous, self-supported 3D interconnected network-based nanomaterials hold immense promise in revolutionizing the field of catalysis. These materials combine two critical features; a large accessible surface and an overall active surface that leads to substantial catalytic effects. In this study, we developed a novel class of 3D composite material composed of zinc oxide tetrapods (ZOT) and polyethylene glycol (PEG) polymer, specifically designed for photocatalysis.

View Article and Find Full Text PDF

The escalating prevalence of bacterial infections presents a formidable challenge to current global healthcare systems. Rapid identification and quantification of bacterial pathogens with anticipated sensitivity and selectivity are crucial for targeted therapeutic interventions to mitigate disease burden, drug resistance, and further transmission. Concurrently, there is a pressing need to innovate novel approaches to combat infections and counter antibiotic resistance.

View Article and Find Full Text PDF

The World Health Organization (WHO) has declared the monkeypox outbreak a public health emergency, as there is no specific therapeutics for monkeypox virus (MPXV) disease. This study focused on docking various commercial drugs and plant-derived compounds against the E8 envelope protein crucial for MPXV attachment and pathogenesis. The target protein structure was modeled based on the vaccinia virus D8L protein.

View Article and Find Full Text PDF

In addition to several other malignancies, the ligand-activated aryl hydrocarbon receptor (AhR) signaling pathway has been found to enhance the risk of triple-negative breast cancer (TNBC). Many natural compounds of pharmaceutical importance are identified as antagonistic exogenous ligands of AhR. The expressional lack of hormone receptors coupled with adverse prognosis leads to the absence of molecular-targeted therapy in TNBC.

View Article and Find Full Text PDF

When addressing bone defects resulting from trauma, infection, or tumors, the use of allogenic bone is often necessary. While autografts are considered the standard, they have limitations and can lead to donor site morbidity. Consequently, there has been exploration into the feasibility of utilizing allogenic bone and bone graft replacements.

View Article and Find Full Text PDF